From: A retrospective analysis of patient-specific factors on voriconazole clearance
Mean (SD) | |
---|---|
Male/Female | 50/13 |
Age (yr) | 70.8 (11.0) |
Body Weight (kg) | 49.7 (9.5) |
Body Mass Index (kg/m2) | 19.0 (2.9) |
Albumin (g/dl)a | 2.7 (0.7) |
Creatinine clearance (ml/min)a | 67.4 (31.9) |
AST (IU/L)a | 32.9 (28.6) |
ALT (IU/L)a | 32.9 (35.9) |
ALP (IU/L)a | 386.6 (409.2) |
γGTP (IU/L)a | 103.7 (173.1) |
T-Bil (mg/dl)a | 0.6 (0.8) |
C reactive protein (mg/dl)a | 5.6 (6.4) |
Daily dose (mg/day)a | 273 (89.8) |
Trough concentration (μg/ml)a | 3.2 (2.3) |
Trough concentration collection date (after initial dose)a | |
with loading dose | 9.7 (13) |
without loading dose | 11.1 (9.5) |
Purpose of voriconazole administration prophylaxis/treatment | 3/60 |
Diagnosis and treatment department | |
Hematology/Pulmonology/Rheumatology/Other | 41/17/4/1 |
Concomitant medicationa | |
Glucocorcicoid | 28 |
Macrolide Antibiotics | 2 |